Mobile Site ›

Circulating Tumor Cells and the CellSearch Assay



Subscribe

Receive notification when new Hot Topics are published:

Introduction

Slide 1

March 2011


Welcome to Mayo Medical Laboratories' Hot Topics. These presentations provide short discussions of current topics and may be helpful to you in your practice.

Our presenters for this program are Kevin Halling, MD, PhD and Michael Campion from the Division of Laboratory Genetics and Anatomic Pathology at Mayo Clinic. Dr. Halling will provide an overview of the metastatic process in cancer and how circulating tumor cell counts influence prognosis and overall survival in metastatic breast, colorectal, or prostate cancer. Mike Campion will discuss the technical aspects of a novel assay for enumerating circulating tumor cells in peripheral blood and cite several clinical trial studies describing the clinical utility of this assay.

Mike Campion and I are going to discuss the use of the Cell Search assay for the detection of circulating tumor cells. We believe that circulating tumor cell analysis is a valuable new tool for monitoring patients with metastatic cancer and that it will be increasingly used in the clinical management of patients with metastatic cancer.

Introduction

 

Jump to section:


Key